ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

AURA Aura Biosciences Inc

7.40
-0.10 (-1.33%)
Fuera de horario
Última actualización: 15:06:28
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aura Biosciences Inc AURA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.10 -1.33% 7.40 15:06:28
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.44 7.34 7.50 7.40 7.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
27/3/202406:00BWAura Biosciences Reports Fourth Quarter and Full Year 2023..
04/3/202416:35EDGAR2Form 144 - Report of proposed sale of securities
26/2/202406:00BWAura Biosciences to Participate in Upcoming Investor..
23/2/202415:22EDGAR2Form 144 - Report of proposed sale of securities
02/2/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202415:01EDGAR2Form 144 - Report of proposed sale of securities
08/1/202415:11EDGAR2Form 144 - Report of proposed sale of securities
08/1/202406:31EDGAR2Form 8-K - Current report
02/1/202415:29EDGAR2Form 144 - Report of proposed sale of securities
15/12/202315:30EDGAR2Form 144 - Report of proposed sale of securities
07/12/202307:00BWAura Biosciences Announces First Patient Dosed in Global..
09/11/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202315:15EDGAR2Form 8-K - Current report
09/11/202315:05BWAura Biosciences Reports Third Quarter 2023 Financial..
08/11/202306:00BWAura Biosciences to Participate in Upcoming Investor..
07/11/202317:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202317:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202315:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/11/202321:02BWAura Biosciences Announces Pricing of Public Offering of..
06/11/202315:22EDGAR2Form 144 - Report of proposed sale of securities
06/11/202315:20EDGAR2Form 144 - Report of proposed sale of securities
06/11/202315:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/11/202315:08BWAura Biosciences Announces Proposed Public Offering of..
06/11/202315:01EDGAR2Form 8-K - Current report
06/11/202314:50DJNAura Biosciences Gets FDA Agreement Regarding Phase 3..
06/11/202314:00BWAura Biosciences Receives FDA Agreement Under Special..
03/11/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:16EDGAR2Form 144 - Report of proposed sale of securities
03/11/202315:15EDGAR2Form 144 - Report of proposed sale of securities
03/11/202315:15EDGAR2Form 144 - Report of proposed sale of securities
01/11/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202315:05BWAura Biosciences to Present Updated Phase 2 Data Evaluating..
23/10/202319:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/10/202318:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202315:11EDGAR2Form 8-K - Current report
02/10/202315:05BWAura Biosciences Strengthens and Expands Leadership Team..
09/8/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:05EDGAR2Form 8-K - Current report
09/8/202306:00BWAura Biosciences Reports Second Quarter 2023 Financial..
24/5/202315:05BWAura Biosciences to Participate in Upcoming Investor..
12/5/202306:00BWAura Biosciences to Participate in the JMP Securities Life..
11/5/202315:10BWAura Biosciences Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock